The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years.
Hedge Fund - Baker Bros. Advisors
News, Interviews, and Investor Letters
- First
- << Previous
- 21 - 30
- Next >>
Baker Bros. Opened Positions In These 5 Healthcare Stocks
Julian Baker and Felix Baker founded Baker Bros. Advisors in 2000.
Aquinox Pharmaceuticals Inc (AQXP): Baker Bros. Advisors Pushes Stake to Over 45%
A newly-amended 13D filing with the Securities and Exchange Commission revealed that Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) has signed an Underwriting Agreement with Leerink Partners LLC as representatives...
Seattle Genetics Inc (SGEN): Baker Bros. Advisors Raises Stake
Julian and Felix Baker's Baker Bros.
Biocryst Pharmaceuticals Inc (BCRX): Baker Bros. Advisors Unloads Nearly 4 Million Shares
Julian Baker and Felix Baker's Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst Pharmaceuticals Inc (NASDAQ:BCRX).
Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares
Julian Baker and Felix Baker, the managers of Baker Bros.
Stumbling Biotech Stocks Spell Doom for Baker Bros. Advisors
While several hedge funds have suffered enormous losses this year due to their investments in biotech stocks, the performance of the leading biotech-focused hedge fund Baker Bros.
Billionaire Leone Boosts Stake in This REIT, Ubben Sells More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Hot Moves
It is generally believed that individuals seeking to become millionaires (and who isn't?) need to think and act like millionaires.
Seattle Genetics Inc (SGEN): Baker Bros. Keeps Buying Shares
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors.
- First
- << Previous
- 21 - 30
- Next >>